thiazoles has been researched along with Acute Disease in 160 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 20 (12.50) | 18.7374 |
| 1990's | 24 (15.00) | 18.2507 |
| 2000's | 72 (45.00) | 29.6817 |
| 2010's | 39 (24.38) | 24.3611 |
| 2020's | 5 (3.13) | 2.80 |
| Authors | Studies |
|---|---|
| Crippa, A; Davis, JM; Leucht, S; Orsini, N; Patel, MX; Siafis, S | 1 |
| Ebner, M; Lankeit, M | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Cheon, J; Kang, SG; Kang, SH; Lee, JG; Noh, TI; Shim, JS | 1 |
| Chang, Q; Jing, H; Wang, J; Wu, X; Xu, Y; Zhang, Z | 1 |
| Langer, F; Voigtlaender, M | 1 |
| Akaike, M; Amano, R; Fukuda, D; Hara, T; Ise, T; Kadota, M; Kusunose, K; Matsuura, T; Oomichi, Y; Sangawa, T; Sata, M; Soeki, T; Tobiume, T; Torii, Y; Ueno, R; Wakatsuki, T; Yagi, S; Yamada, H; Yamaguchi, K; Yamazaki, H | 1 |
| Abdel-Razeq, H; Finianos, A; Taher, AT | 1 |
| El Ghaffar, AEA; El-Kowrany, SI; Gamea, GAM; Mady, RF; Shoheib, ZS | 1 |
| Deng, H; Gao, C; Karayal, ON; Li, K; Pan, S; Shi, J; Shu, L; Tang, H; Vanderburg, D; Wang, G; Wang, X; Xie, S; Xu, X; Zhang, H; Zhao, J | 1 |
| Chopra, A; Saluja, M; Venugopalan, A | 1 |
| Bounameaux, H; Fontana, P; Goldhaber, SZ | 1 |
| Faiz, SA; Jimenez, CA; Sahay, S | 1 |
| Ketter, TA | 1 |
| Freeman, K; Jayson, S; Maggs, DJ; Petritz, O; Sanchez-Migallon Guzman, D | 1 |
| Büller, HR; Coppens, M; Middeldorp, S; Schulman, S; van Es, N | 1 |
| Ansell, J; Mantha, S | 1 |
| Ali, S; Baqi, S; Kalam, K; Mumar, S; Raja, K | 1 |
| Lin, D; Liu, B; Lyu, R; Mi, Y; Wang, J; Zhou, C | 1 |
| Dickneite, G; Doerr, B; Herzog, E; Kaspereit, F; Krege, W; Morishima, Y; Mueller-Cohrs, J; Pragst, I | 1 |
| Calabrese, JR; Citrome, L; Dell'Osso, B; Frye, MA; Ketter, TA; Miller, S | 1 |
| Stone, RM; Wolach, O | 1 |
| Ar, MC; Eskazan, AE; Hatemi, İ; Öngören Aydın, S; Soysal, T | 1 |
| Gonzalez, MG; Levy, PD; Peacock, WF; Than, M | 1 |
| Boda, Z | 1 |
| Li, Y; Luo, X; Tan, H; Xu, L | 1 |
| Bonvin, A; Cotte, L; Descotes, J; Mesnil, A; Michallet, M; Nicolini, FE; Vial, T | 1 |
| Buhl, D; Lamkin, S | 1 |
| Díaz-Marsá, M; Rico-Villademoros, F; Sánchez, S | 1 |
| Citrome, L; Glue, P; Karayal, ON; Yang, R | 1 |
| Albitar, M; Bornmann, W; Estrov, Z; Faderl, S; Harris, D; Hazan-Halevy, I; Kantarjian, HM; Liu, Z; Maxwell, D; Pal, A; Peng, Z; Van, Q | 1 |
| Cucchiaro, J; Guarino, J; Loebel, A; Nakamura, M; Ogasa, M; Phillips, D; Severs, J | 1 |
| Lioté, F; Perez-Ruiz, F; Scavulli, J; Terkeltaub, R; Zelman, D | 1 |
| Loebel, A; Lombardo, I; Mandel, FS; Stahl, S | 1 |
| Del Rosso, JQ; Michaels, B; Mobini, N; Momin, SB | 1 |
| Derry, S; McQuay, HJ; Moore, RA | 1 |
| Horiike, S; Kobayashi, T; Kuroda, J; Matsumoto, Y; Mizutani, S; Ohshiro, M; Sasaki, N; Shimazaki, C; Shimura, Y; Taniwaki, M; Tsutsumi, Y; Uchiyama, H; Yamamoto, M | 1 |
| Arslan, M; Erkut, M; Erkut, N; Ersoz, S; Sonmez, M | 1 |
| Schlesinger, N | 1 |
| Shukla, A | 1 |
| Buitelaar, JK; Grootens, KP; Kahn, RS; Peuskens, J; Sabbe, BG; Sitskoorn, MM; van Veelen, NM; Verkes, RJ | 1 |
| Graser, E; Pope, RS; Zychowicz, ME | 1 |
| Bolis, F; Calabrese, F; Fumagalli, F; Luoni, A; Racagni, G; Riva, MA | 1 |
| Chappell, PB; Gurtovaya, O; Ice, KS; Kasuba, B; Sachs, GS; Schwartz, JH; Vanderburg, DG | 1 |
| Cucchiaro, J; Kalali, AH; Loebel, A; Meltzer, HY; Ogasa, M; Phillips, D; Pikalov, A; Schweizer, E; Silva, R; Xu, J | 1 |
| Cañas, F; Correll, CU; Fagiolini, A; Larmo, I; Levy, P; Montes, JM; Papageorgiou, G; Rossi, A; Zink, M | 1 |
| Bramanti, P; Cappellani, A; Cuzzocrea, S; Esposito, E; Galuppo, M; Impellizzeri, D; Mazzon, E; Paterniti, I; Riccardi, L | 1 |
| Filkowski, MM; Ghaemi, SN; Gilmer, W; Holtzman, NS; Loebel, A; Logvinenko, T; Masand, P; Mulligan, M; Pae, CU; Patkar, A; Pirok, E; Thommi, SB; Vöhringer, PA; Whitham, EA; Ziffra, M | 1 |
| Blum, W; Caligiuri, M; Croce, CM; Garzon, R; Kauffman, M; Klisovic, R; Marcucci, G; Na, C; Ranganathan, P; Santhanam, R; Shacham, S; Walker, A; Yu, X | 1 |
| Chugunov, AV; Sal'nikova, GS | 1 |
| Goecke, H; Guarda, FJ; Méndez, GP; Vega, J | 1 |
| Capapey, J; Colom, F; Goikolea, JM; Grande, I; Sanchez-Moreno, J; Torres, I; Undurraga, J; Valentí, M; Vieta, E | 1 |
| Creutzig, U; Hählen, K; Harbott, J; Huismans, DR; Kaspers, GJ; Pieters, R; Slater, RM; Veerman, AJ; Zimmermann, M; Zwaan, CM | 1 |
| Besra, SE; Bhattacharya, S; Das, M; Ghosh, P; Gomes, A; Majumdar, J; Mitra, S; Murmu, N; Sur, P; Vedasiromoni, JR | 1 |
| Georganas, C; Kosmaoglou, EV; Papatsoris, AG; Pardalidis, NP | 1 |
| Aburatani, H; Blumberg, RS; Kadowaki, T; Matsuhashi, N; Nagai, R; Nakajima, A; Saubermann, LJ; Terauchi, Y; Wada, K; Zhao, S | 1 |
| Ackerson, L; Chan, KA; Everhart, JE; Gurwitz, JH; Hurley, JS; Martinson, B; Moseley, RH; Platt, R; Selby, JV; Terrault, N; Truman, A | 1 |
| Giller, E; Ice, K; Keck, PE; Potkin, S; Versiani, M; West, SA | 1 |
| Bernal, MR; Calle-Pascual, AL; Fernández-Cruz, A; Goldfine, A; Horton, E; Jarolim, P; Libby, P; Nuzzo, R; Schönbeck, U; Varo, JJ; Varo, N; Veves, A; Vicent, D | 1 |
| Frendin, J; Viking Höglund, O | 1 |
| Koyama, T; Nakagawa, S | 1 |
| Hiran, S; Mazumdar, D; Sarma, PS | 1 |
| Borer, LR; Peel, JE; Schawalder, P; Seewald, W; Spreng, DE | 1 |
| Kane, JM | 1 |
| Brook, S | 1 |
| Chen, Z; Chua, BH; Chua, CC; Gao, J; Hamdy, R; Landy, CL; Liu, X | 1 |
| Chem, YC; Cheng, TT; Chiu, CK; Lai, HM | 1 |
| Gaĭgalas, LM; Guzeva, VI; Razumovskiĭ, MA | 1 |
| Dew, RE; Hughes, D | 1 |
| Alvarez, E; Barrachina, J; Oller, S; Pascual, JC; Pérez, V; Soler, J | 1 |
| Battistini, G; Cassano, GB; Cassano, P; Gemignani, A; Lattanzi, L; Navari, S; Soldani, F | 1 |
| Solov'ev, IE; Solov'eva, OA | 1 |
| Minov, C | 1 |
| Ehret, J; Hazaray, E; McDougle, CJ; Petti, TA; Posey, DJ | 1 |
| Benattia, I; Brook, S; Romano, SJ; Siu, CO; Walden, J | 1 |
| Johnson, CE; Mason, MN; Piasecki, M | 1 |
| Lutsep, HL | 1 |
| Cleveland, NJ; Dewitt, CD; Heard, K | 1 |
| Goikolea, JM; Vieta, E | 1 |
| Cunha, FQ; Michelin, MA; Silva, JS | 1 |
| English, P; Ice, K; Keck, PE; Potkin, SG; Segal, S | 1 |
| Filatova, EG; Istomina, OI; Kondrikov, AV | 1 |
| Hsiao, FY; Huang, WF; Shih, YT; Tsai, YW; Wen, YW | 1 |
| Adler, CM; Strakowski, SM; Weinstein, SK | 1 |
| Barak, Y; Baruch, Y; Mazeh, D; Plopski, I | 1 |
| Bold, G; Furet, P; Guagnano, V; Meyer, T; Roesel, J | 1 |
| Alam, S; Bhatnagar, S | 1 |
| Cheng, YC; Huang, MJ; Lin, S; Liu, CR; Liu, HE | 1 |
| Khan, SS; Mican, LM | 1 |
| Ainoon, O; Cheong, SK; Fazlina, N; Hamidah, H; Hamidah, NH; Jamal, R; Maha, A; Zarina, AL; Zulkifli, SZ | 1 |
| Mellacheruvu, S; Norton, JW; Schweinfurth, J | 1 |
| De Keyser, J; Koch, MW; Luijckx, GJ; Stewart, RE; Uyttenboogaart, M; Vroomen, PC | 1 |
| Ice, K; Loebel, A; Lombardo, I; Warrington, L | 1 |
| Chua, SE; Chung, AK | 1 |
| Loebel, A; Siu, C; Warrington, L; Yang, R; Zimbroff, D | 1 |
| Baiza-Durán, LM; Cruz, R; González, JR; Quintana-Hau, JD; Tornero-Montaño, R; Vega, L | 1 |
| Duggal, HS; Singh, I | 1 |
| Cuesta, B; Fernandez-Alonso, M; Galar, A; García-Muñoz, R; Merino, J; Moreno, C; Panizo-Morgado, E; Panizol, C; Ponz-Sarvisê, M; Prosper, F; Rodríguez-Otero, P; Rubio, M | 1 |
| Abdalla, GK; Castro, EC; Faria, GE; Michelin, MA; Reis, MA; Silva, KT | 1 |
| Cutler, AJ; Hamilton, J; Kalali, AH; Weiden, PJ; Wolfgang, CD | 1 |
| Agid, O; Kapur, S; Loebel, A; Siu, C; Warrington, L | 1 |
| Catti, A | 1 |
| Oyanagui, Y | 1 |
| López, JM | 1 |
| Justus, C; Quirke, JF; Van Bree, H | 1 |
| Grendell, JH; Luthen, RE | 1 |
| Beelen, RH; Broekhoven, MG; Langenhuijsen, MM; Ossenkoppele, GJ; van de Loosdrecht, AA | 1 |
| Bernat, A; Defreyn, G; Herbert, JM; Maffrand, JP; Mares, AM | 1 |
| De Keyser, J; Diener, HC; Hacke, W; Hantson, L; Hennerici, M; Rådberg, J | 1 |
| Elgie, AW; Sargent, JM; Taylor, CG; Williamson, C | 1 |
| Borg, AG; Burgess, R; Fisher, A; Grey, M; Wood, P; Yin, JA | 1 |
| Grotta, J | 1 |
| Bosch, HC; Hettich, M; Sigmund, R | 1 |
| Lodder, J | 1 |
| Bonomini, L; DeFranco, P; Friedman, G; Jacobs, M; Kaplan, B; Lyman, N; Mulgaonkar, SP; Viscuso, R | 1 |
| Alton, P; Elgie, AW; Noordhuis, P; Peters, GJ; Sargent, JM; Taylor, CG; Williamson, CJ | 1 |
| Buffenstein, A; Feighner, J; Ferguson, J; Harrigan, EP; Jaffe, W; Keck, P; Morrissey, MR | 1 |
| Demchuk, AM; Hantson, L; Jauss, M; Kasner, SE; Krieger, DW | 1 |
| Hallal, H; Pérez-Gracia, A; Rausell, V; Salinas, E | 1 |
| Daniel, DG; Harrigan, EP; Lakshminarayanan, M; Potkin, SG; Reeves, KR; Zimbroff, DL | 1 |
| Barberà, JA; Chung, KF; Gómez, FP; Iglesia, R; Marrades, RM; Roca, J; Rodriguez-Roisin, RM | 1 |
| Andrade, RJ; Bellot, V; Bermudez, F; Cárdenas, F; Fernandez, MC; Garcia-Escaño, MD; Gomez-Outes, A; Hervás, A; Lucena, MI; Martin-Vivaldi, R; Nogueras, F; Pelaez, G; Romero, M; Salmerón, J | 1 |
| Piotrowski, J; Slomiany, A; Slomiany, BL | 1 |
| Agapov, VS; Aleksashina, IP; Liapunov, NA; Tarasenko, SV; Trukhina, GM | 1 |
| Blasucci, L; Goetz, CG; Kujawa, K; Leurgans, S; Raman, R | 1 |
| Cortens, M; Diener, HC; Ford, G; Grotta, J; Hacke, W; Kaste, M; Koudstaal, PJ; Wessel, T | 1 |
| Fisher, M; Schaebitz, W | 1 |
| Brook, S; Gunn, KP; Lucey, JV | 1 |
| Cañas, F | 1 |
| Dreiser, RL; Le Parc, JM; Lleu, PL; Vélicitat, P | 1 |
| Baturone, M; Kneer, W; Sigmund, R; Vidal, L | 1 |
| Conti, M; Gandolfo, C; Sandercock, P | 1 |
| Caley, CF; Cooper, CK | 1 |
| Sareen, D | 1 |
| Bergman, J; Hoeijmakers, M; Horspool, LJ; Nell, T; Van Laar, P | 1 |
| Altman, R; Berman, SG; Del Rio, F; Gonzalez, C; Lopez, R; Luciardi, HL; Muntaner, J | 1 |
| Ganote, CE; Jennings, RB; Kloner, RA; Reimer, KA | 1 |
| Alfano, S; Biolchini, A; Careddu, P; Zavattini, G | 1 |
| Fujii, Y; Hongo, T | 1 |
| Burdick, L; Fasoli, A; Mangiarotti, R; Pini, C | 1 |
| Rybak, LP; Scott, V; Whitworth, C | 1 |
| Dai, S | 1 |
| Cherner, JA; Cloud, ML; Latz, JE; Offen, WW | 1 |
| Bonetti, F; Monafo, V; Nespoli, L; Savio, G; Terracciano, L | 1 |
| Bianchi Porro, G | 1 |
| Bianchi Porro, G; Cook, T; Dicenta, C; Humphries, TJ | 1 |
| Dammann, HG; Müller, P; Simon, B | 1 |
| Fölsch, UR; Hartmann, H | 1 |
| Gerok, W; Knauf, H; Missmahl, M; Mutschler, E; Schölmerich, J | 1 |
| Kimmig, JM | 1 |
| Issekutz, AC; Szpejda, M | 1 |
| Molina, J | 1 |
| Kanaide, H; Nakamura, M; Taira, Y | 1 |
| Abkarovich, GF; Vakaliuk, PM | 1 |
| Bosio, G; Soranzo, ML | 1 |
| Fanuele, G; Stoppoloni, G | 1 |
26 review(s) available for thiazoles and Acute Disease
| Article | Year |
|---|---|
Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia.
Topics: Acute Disease; Administration, Oral; Antipsychotic Agents; Aripiprazole; Clozapine; Delayed-Action Preparations; Dose-Response Relationship, Drug; Haloperidol; Humans; Imidazoles; Indoles; Isoxazoles; Lurasidone Hydrochloride; Olanzapine; Paliperidone Palmitate; Piperazines; Piperidines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Thiophenes | 2020 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Direct oral anticoagulants for the treatment of cancer-associated venous thromboembolism. What do we know so far?
Topics: Acute Disease; Administration, Oral; Anticoagulants; Clinical Trials, Phase III as Topic; Dabigatran; Guideline Adherence; Heparin, Low-Molecular-Weight; Humans; Long-Term Care; Neoplasms; Pyrazoles; Pyridines; Pyridones; Risk Factors; Rivaroxaban; Secondary Prevention; Thiazoles; Venous Thromboembolism | 2017 |
The use of direct oral anticoagulants in the treatment of acute venous thromboembolism in cancer patients.
Topics: Acute Disease; Administration, Oral; Anticoagulants; Dalteparin; Gastrointestinal Neoplasms; Humans; Pyridines; Randomized Controlled Trials as Topic; Thiazoles; Venous Thromboembolism | 2018 |
Direct oral anticoagulants in the treatment and long-term prevention of venous thrombo-embolism.
Topics: Acute Disease; Administration, Oral; Antithrombins; Benzimidazoles; beta-Alanine; Clinical Trials, Phase III as Topic; Dabigatran; Hemorrhage; Humans; Long-Term Care; Morpholines; Perioperative Care; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thiophenes; Treatment Outcome; Venous Thromboembolism; Vitamin K | 2014 |
Pleural effusions in acute and chronic leukemia and myelodysplastic syndrome.
Topics: Acute Disease; Biopsy; Bone Marrow; Chronic Disease; Dasatinib; Humans; Leukemia; Myelodysplastic Syndromes; Pleura; Pleural Effusion; Prognosis; Protein Kinase Inhibitors; Pyrimidines; Thiazoles | 2014 |
Acute and maintenance treatments for bipolar depression.
Topics: Acute Disease; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Depression; Dibenzothiazepines; Drug Therapy, Combination; Fluoxetine; Humans; Isoindoles; Lurasidone Hydrochloride; Olanzapine; Quetiapine Fumarate; Selective Serotonin Reuptake Inhibitors; Thiazoles | 2014 |
Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials.
Topics: Acute Disease; Administration, Oral; Anticoagulants; Benzimidazoles; Clinical Trials, Phase III as Topic; Dabigatran; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Male; Morpholines; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Thiazoles; Thiophenes; Venous Thromboembolism; Vitamin K | 2014 |
Indirect comparison of dabigatran, rivaroxaban, apixaban and edoxaban for the treatment of acute venous thromboembolism.
Topics: Acute Disease; Adult; Aged; Anticoagulants; Clinical Trials, Phase III as Topic; Dabigatran; Female; Hemorrhage; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Recurrence; Risk Assessment; Rivaroxaban; Survival Analysis; Thiazoles; Venous Thrombosis | 2015 |
Balancing benefits and harms of treatments for acute bipolar depression.
Topics: Acute Disease; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Drug Combinations; Fluoxetine; Humans; Isoindoles; Lamotrigine; Lurasidone Hydrochloride; Multicenter Studies as Topic; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Thiazoles; Triazines; Weight Gain | 2014 |
Target-specific Oral Anticoagulants in the Emergency Department.
Topics: Acute Disease; Administration, Oral; Anticoagulants; Blood Coagulation Tests; Dabigatran; Drug Interactions; Drug Monitoring; Emergency Service, Hospital; Factor Xa Inhibitors; Hemorrhage; Humans; Practice Guidelines as Topic; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Venous Thromboembolism | 2016 |
[Treatment with inhibitors of new oral direct anticoagulants in patients with severe bleedings or urgent surgical procedures. The new dabigatran antidote: the place of idarucizumab in clinical practice].
Topics: Acute Disease; Administration, Oral; Ambulatory Care; Antibodies, Monoclonal, Humanized; Anticoagulants; Antidotes; Antithrombins; Dabigatran; Factor Xa; Factor Xa Inhibitors; Hemorrhage; Humans; Pyrazoles; Pyridines; Pyridones; Recombinant Proteins; Rivaroxaban; Severity of Illness Index; Surgical Procedures, Operative; Thiazoles | 2016 |
Single dose oral meloxicam for acute postoperative pain in adults.
Topics: Acute Disease; Administration, Oral; Adult; Analgesics; Cyclooxygenase Inhibitors; Humans; Meloxicam; Pain, Postoperative; Thiazines; Thiazoles | 2009 |
New agents for the treatment of gout and hyperuricemia: febuxostat, puricase, and beyond.
Topics: Acute Disease; Chronic Disease; Colchicine; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Polyethylene Glycols; Thiazoles; Urate Oxidase | 2010 |
Practical guidance for prescribing ziprasidone in acute manic or mixed episodes of bipolar I disorder.
Topics: Acute Disease; Antipsychotic Agents; Bipolar Disorder; Humans; Molecular Structure; Piperazines; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Thiazoles | 2011 |
Lower rate of depressive switch following antimanic treatment with second-generation antipsychotics versus haloperidol.
Topics: Acute Disease; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Depression; Depressive Disorder; Dibenzothiazepines; Double-Blind Method; Drug Industry; Haloperidol; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Research Support as Topic; Risperidone; Thiazoles | 2013 |
[Extrapyramidal syndrome].
Topics: Acute Disease; Akathisia, Drug-Induced; Antipsychotic Agents; Basal Ganglia Diseases; Dibenzothiazepines; Dopamine D2 Receptor Antagonists; Dystonia; Humans; Indoles; Isoindoles; Parkinsonian Disorders; Quetiapine Fumarate; Receptors, Muscarinic; Receptors, Serotonin; Risperidone; Serotonin Antagonists; Syndrome; Thiazoles | 2003 |
Intramuscular ziprasidone: moving beyond the conventional in the treatment of acute agitation in schizophrenia.
Topics: Acute Disease; Antipsychotic Agents; Brief Psychiatric Rating Scale; Dose-Response Relationship, Drug; Humans; Injections, Intramuscular; Piperazines; Psychomotor Agitation; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology; Serotonin Antagonists; Thiazoles; Treatment Outcome | 2003 |
Repinotan, A 5-HT1A agonist, in the treatment of acute ischemic stroke.
Topics: Acute Disease; Aged; Benzopyrans; Brain Ischemia; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Neuroprotective Agents; Serotonin Receptor Agonists; Stroke; Thiazoles; Treatment Outcome | 2005 |
Atypical antipsychotics: newer options for mania and maintenance therapy.
Topics: Acute Disease; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Humans; Lithium Carbonate; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Thiazoles | 2005 |
Ziprasidone for the treatment of acute manic or mixed episodes associated with bipolar disorder.
Topics: Acute Disease; Administration, Oral; Antipsychotic Agents; Bipolar Disorder; Dopamine D2 Receptor Antagonists; Humans; Piperazines; Serotonin 5-HT2 Receptor Antagonists; Thiazoles; Treatment Outcome | 2007 |
[Ebrotidine-induced acute hepatitis].
Topics: Acute Disease; Adult; Benzenesulfonates; Chemical and Drug Induced Liver Injury; Chronic Disease; Female; Gastritis; Histamine H2 Antagonists; Humans; Thiazoles | 1999 |
An overview of acute stroke therapy: past, present, and future.
Topics: Acute Disease; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Antibodies; Brain Ischemia; Calcium Channel Blockers; Cardiovascular Agents; Cell Adhesion Molecules; Clinical Trials as Topic; Cytidine Diphosphate Choline; Cytokines; Drug Therapy, Combination; Fibrinolytic Agents; Free Radical Scavengers; gamma-Aminobutyric Acid; Growth Substances; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; N-Methylaspartate; Neuroprotective Agents; Nootropic Agents; Piperidines; Stroke; Thiazoles; Thrombolytic Therapy | 2000 |
Lubeluzole for acute ischaemic stroke.
Topics: Acute Disease; Brain Ischemia; Humans; Neuroprotective Agents; Piperidines; Thiazoles | 2002 |
Ziprasidone: the fifth atypical antipsychotic.
Topics: Acute Disease; Antipsychotic Agents; Basal Ganglia Diseases; Body Weight; Headache; Humans; Injections, Intramuscular; Long QT Syndrome; Nausea; Piperazines; Randomized Controlled Trials as Topic; Schizophrenia; Thiazoles; Treatment Outcome; Weight Gain | 2002 |
Neuroprotective agents in acute ischemic stroke.
Topics: Acute Disease; Adult; Aged; Animals; Antioxidants; Calcium Channel Blockers; Chlormethiazole; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Excitatory Amino Acid Antagonists; Excitatory Amino Acids; Forecasting; GABA Modulators; Guanidines; Humans; Imidazoles; Middle Aged; Naltrexone; Narcotic Antagonists; Neuroprotective Agents; Pipecolic Acids; Piperidines; Quinoxalines; Rats; Receptors, N-Methyl-D-Aspartate; Reperfusion Injury; Stroke; Thiazoles | 2002 |
50 trial(s) available for thiazoles and Acute Disease
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Intramuscular ziprasidone versus haloperidol for managing agitation in Chinese patients with schizophrenia.
Topics: Acute Disease; Adult; Antipsychotic Agents; China; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; Injections, Intramuscular; Least-Squares Analysis; Male; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Schizophrenia; Thiazoles; Time Factors; Young Adult | 2013 |
Effectiveness of chloroquine and inflammatory cytokine response in patients with early persistent musculoskeletal pain and arthritis following chikungunya virus infection.
Topics: Acute Disease; Alphavirus Infections; Arthritis; Chikungunya Fever; Chloroquine; Cytokines; Disease Management; Epidemics; Female; Humans; India; Male; Meloxicam; Middle Aged; Musculoskeletal Pain; Pain Measurement; Thiazines; Thiazoles; Treatment Outcome | 2014 |
Effectiveness and tolerability of oral ziprasidone in psychiatric inpatients with an acute exacerbation of schizophrenia or schizoaffective disorder: a multicenter, prospective, and naturalistic study.
Topics: Acute Disease; Adult; Antipsychotic Agents; Brief Psychiatric Rating Scale; Drug Administration Schedule; Female; Hospitalization; Humans; In Vitro Techniques; Length of Stay; Piperazines; Prospective Studies; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Thiazoles; Treatment Outcome | 2009 |
Effect of ziprasidone dose on all-cause discontinuation rates in acute schizophrenia and schizoaffective disorder: a post-hoc analysis of 4 fixed-dose randomized clinical trials.
Topics: Acute Disease; Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Piperazines; Proportional Hazards Models; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Thiazoles; Time Factors; Treatment Outcome | 2009 |
Lurasidone in the treatment of acute schizophrenia: a double-blind, placebo-controlled trial.
Topics: Acute Disease; Adult; Antipsychotic Agents; Brief Psychiatric Rating Scale; Double-Blind Method; Female; Humans; Isoindoles; Lurasidone Hydrochloride; Male; Middle Aged; Psychometrics; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome; Young Adult | 2009 |
Effects on cognitive functioning after olanzapine-ziprasidone crossover in recent-onset schizophrenia.
Topics: Acute Disease; Adolescent; Adult; Benzodiazepines; Cognition; Cross-Over Studies; Double-Blind Method; Drug Substitution; Female; Follow-Up Studies; Humans; Male; Neuropsychological Tests; Olanzapine; Piperazines; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome; Young Adult | 2010 |
Efficacy and safety of adjunctive oral ziprasidone for acute treatment of depression in patients with bipolar I disorder: a randomized, double-blind, placebo-controlled trial.
Topics: Acute Disease; Adolescent; Adult; Aged; Antimanic Agents; Bipolar Disorder; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lamotrigine; Lithium; Male; Middle Aged; Piperazines; Serotonin Antagonists; Thiazoles; Treatment Outcome; Triazines; Valproic Acid; Young Adult | 2011 |
Lurasidone in the treatment of schizophrenia: a randomized, double-blind, placebo- and olanzapine-controlled study.
Topics: Acute Disease; Adult; Antipsychotic Agents; Benzodiazepines; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Isoindoles; Lurasidone Hydrochloride; Male; Middle Aged; Olanzapine; Patient Admission; Psychiatric Status Rating Scales; Schizophrenia; Thiazoles; Treatment Outcome | 2011 |
A 6 week randomized double-blind placebo-controlled trial of ziprasidone for the acute depressive mixed state.
Topics: Acute Disease; Adult; Antipsychotic Agents; Bipolar Disorder; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Thiazoles; Treatment Outcome | 2012 |
Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial.
Topics: Acute Disease; Administration, Oral; Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Piperazines; Placebos; Psychiatric Status Rating Scales; Severity of Illness Index; Thiazoles; Treatment Outcome | 2003 |
Elevated plasma levels of the atherogenic mediator soluble CD40 ligand in diabetic patients: a novel target of thiazolidinediones.
Topics: Acute Disease; Adult; Aged; Arteriosclerosis; Body Mass Index; CD40 Ligand; Chromans; Chronic Disease; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Longitudinal Studies; Male; Metformin; Pilot Projects; Receptors, Cytoplasmic and Nuclear; Reference Values; Risk Factors; Solubility; Spain; Thiazoles; Thiazolidinediones; Transcription Factors; Treatment Outcome; Troglitazone | 2003 |
Analgesic effect of meloxicam in canine acute dermatitis--a pilot study.
Topics: Acute Disease; Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cephalexin; Dermatitis; Dog Diseases; Dogs; Double-Blind Method; Meloxicam; Pain; Pain Measurement; Pilot Projects; Severity of Illness Index; Thiazines; Thiazoles; Treatment Outcome | 2002 |
A single-blind, randomized, controlled trial to assess the efficacy and tolerability of rofecoxib, diclofenac sodium, and meloxicam in patients with acute gouty arthritis.
Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Gouty; Diclofenac; Female; Humans; Lactones; Male; Meloxicam; Middle Aged; Single-Blind Method; Sulfones; Thiazines; Thiazoles | 2004 |
[Movalis in the treatment of acute dorsopathy].
Topics: Acute Disease; Adult; Analgesics, Non-Narcotic; Female; Humans; Male; Meloxicam; Spinal Diseases; Thiazines; Thiazoles | 2004 |
Ziprasidone in the acute treatment of borderline personality disorder in psychiatric emergency services.
Topics: Acute Disease; Administration, Oral; Adult; Antipsychotic Agents; Borderline Personality Disorder; Drug Administration Schedule; Emergency Services, Psychiatric; Female; Humans; Male; Piperazines; Psychiatric Status Rating Scales; Thiazoles; Treatment Outcome | 2004 |
Pramipexole in treatment-resistant depression: an extended follow-up.
Topics: Acute Disease; Adult; Aged; Benzothiazoles; Depressive Disorder, Major; Dopamine Agonists; Drug Administration Schedule; Drug Resistance; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pramipexole; Prospective Studies; Surveys and Questionnaires; Thiazoles; Treatment Outcome | 2004 |
Ziprasidone and haloperidol in the treatment of acute exacerbation of schizophrenia and schizoaffective disorder: comparison of intramuscular and oral formulations in a 6-week, randomized, blinded-assessment study.
Topics: Acute Disease; Administration, Oral; Adult; Affective Disorders, Psychotic; Brief Psychiatric Rating Scale; Demography; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Haloperidol; Humans; Injections, Intramuscular; Male; Manifest Anxiety Scale; Piperazines; Schizophrenia; Severity of Illness Index; Thiazoles; Time Factors; Treatment Outcome; Withholding Treatment | 2005 |
Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial.
Topics: Acute Disease; Adult; Aged; Antipsychotic Agents; Bipolar Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Hospitalization; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Thiazoles; Treatment Outcome | 2005 |
[Efficacy of movalis in the treatment of acute low back pains].
Topics: Acute Disease; Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Anxiety; Depression; Drug Administration Schedule; Female; Humans; Injections, Intramuscular; Low Back Pain; Male; Meloxicam; Middle Aged; Muscle, Skeletal; Psychology; Radiculopathy; Surveys and Questionnaires; Thiazines; Thiazoles; Treatment Outcome | 2005 |
Intramuscular ziprasidone treatment of acute psychotic agitation in elderly patients with schizophrenia.
Topics: Acute Disease; Aged; Aged, 80 and over; Antipsychotic Agents; Drug Administration Schedule; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Piperazines; Psychomotor Agitation; Psychotic Disorders; Schizophrenia; Thiazoles | 2006 |
Moderate hyperglycaemia is associated with favourable outcome in acute lacunar stroke.
Topics: Acute Disease; Aged; Aged, 80 and over; Blood Glucose; Brain Infarction; Female; Humans; Hyperglycemia; Male; Middle Aged; Neuroprotective Agents; Piperidines; Prognosis; Severity of Illness Index; Stroke; Thiazoles; Treatment Outcome | 2007 |
Comparison of ziprasidone and aripiprazole in acutely ill patients with schizophrenia or schizoaffective disorder: a randomized, double-blind, 4-week study.
Topics: Acute Disease; Adult; Affective Disorders, Psychotic; Antipsychotic Agents; Aripiprazole; Blood Glucose; Diagnostic and Statistical Manual of Mental Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Dyspepsia; Electrocardiography; Fasting; Humans; Lipids; Nausea; Piperazines; Prolactin; Quinolones; Schizophrenia; Severity of Illness Index; Thiazoles; Time Factors; Treatment Outcome; Weight Loss | 2007 |
Four-week, double-blind, placebo- and ziprasidone-controlled trial of iloperidone in patients with acute exacerbations of schizophrenia.
Topics: Acute Disease; Adolescent; Adult; Aged; Antipsychotic Agents; Double-Blind Method; Drug Administration Schedule; Female; Humans; Isoxazoles; Male; Middle Aged; Piperazines; Piperidines; Prospective Studies; Schizophrenia; Thiazoles; Treatment Outcome | 2008 |
Early onset of antipsychotic response in the treatment of acutely agitated patients with psychotic disorders.
Topics: Acute Disease; Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Female; Hospitalization; Humans; Male; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Psychotic Disorders; Thiazoles; Time Factors; Treatment Outcome | 2008 |
Controlled clinical study with Fentiazac suspension in painful inflammatory diseases of children.
Topics: Acetates; Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Benzydamine; Child; Child, Preschool; Double-Blind Method; Female; Fever; Humans; Inflammation; Male; Suspensions; Thiazoles | 1983 |
Treatment of acute tendinitis and bursitis with fentiazac--a double-blind comparison with placebo.
Topics: Acetates; Acute Disease; Adult; Anti-Inflammatory Agents, Non-Steroidal; Bursitis; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Female; Humans; Male; Placebos; Tendinopathy; Thiazoles | 1982 |
Lubeluzole in acute ischemic stroke. A double-blind, placebo-controlled phase II trial. Lubeluzole International Study Group.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Brain Ischemia; Cardiovascular Agents; Carotid Artery Diseases; Cerebrovascular Disorders; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Injections, Intravenous; Logistic Models; Male; Middle Aged; Multivariate Analysis; Piperidines; Placebos; Safety; Thiazoles | 1996 |
Lubeluzole treatment of acute ischemic stroke. The US and Canadian Lubeluzole Ischemic Stroke Study Group.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Brain Ischemia; Cerebrovascular Disorders; Double-Blind Method; Female; Heart Diseases; Humans; Male; Middle Aged; Mortality; Neuroprotective Agents; Piperidines; Survival Analysis; Thiazoles; Treatment Outcome | 1997 |
Efficacy and tolerability of intramuscular and oral meloxicam in patients with acute lumbago: a comparison with intramuscular and oral piroxicam.
Topics: Activities of Daily Living; Acute Disease; Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Chi-Square Distribution; Drug Administration Schedule; Female; Humans; Injections, Intramuscular; Low Back Pain; Male; Meloxicam; Middle Aged; Movement; Pain; Pain Measurement; Piroxicam; Thiazines; Thiazoles | 1997 |
Ziprasidone 40 and 120 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 4-week placebo-controlled trial.
Topics: Acute Disease; Adolescent; Adult; Aged; Antipsychotic Agents; Double-Blind Method; Electrocardiography; Female; Humans; Male; Middle Aged; Piperazines; Psychotic Disorders; Schizophrenia; Thiazoles | 1998 |
Early clinical and radiological predictors of fatal brain swelling in ischemic stroke.
Topics: Acute Disease; Aged; Brain Edema; Brain Ischemia; Case-Control Studies; Cerebral Arteries; Female; Hospital Mortality; Humans; Male; Middle Aged; Neuroprotective Agents; Piperidines; Prognosis; Risk Factors; Severity of Illness Index; Thiazoles; Tomography, X-Ray Computed | 1999 |
Ziprasidone 80 mg/day and 160 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 6-week placebo-controlled trial. Ziprasidone Study Group.
Topics: Acute Disease; Adolescent; Adult; Aged; Antipsychotic Agents; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Thiazoles | 1999 |
Gas exchange response to a PAF receptor antagonist, SR 27417A, in acute asthma: a pilot study.
Topics: Acute Disease; Adult; Airway Resistance; Asthma; Blood Flow Velocity; Blood Gas Analysis; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Male; Pilot Projects; Platelet Activating Factor; Platelet Aggregation; Platelet Membrane Glycoproteins; Pulmonary Circulation; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Thiazoles; Ventilation-Perfusion Ratio | 1999 |
[The use of nitatsid and gipozol'-N in the combined treatment of acute inflammatory diseases of the maxillofacial area].
Topics: Acute Disease; Aerosols; Anti-Infective Agents; Cellulitis; Chloramphenicol; Combined Modality Therapy; Drug Combinations; Face; Focal Infection, Dental; Humans; Plant Oils; Stomatognathic Diseases; Thiazoles; Time Factors; Uracil; Vitamin A; Vitamin E; Vitamin K | 2000 |
Lubeluzole in acute ischemic stroke treatment: A double-blind study with an 8-hour inclusion window comparing a 10-mg daily dose of lubeluzole with placebo.
Topics: Acute Disease; Aged; Double-Blind Method; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Male; Neuroprotective Agents; Piperidines; Placebos; Severity of Illness Index; Stroke; Thiazoles; Treatment Outcome | 2000 |
Intramuscular ziprasidone compared with intramuscular haloperidol in the treatment of acute psychosis. Ziprasidone I.M. Study Group.
Topics: Acute Disease; Adult; Aged; Antipsychotic Agents; Brief Psychiatric Rating Scale; Drug Administration Schedule; Female; Haloperidol; Hospitalization; Humans; Injections, Intramuscular; Male; Middle Aged; Piperazines; Psychotic Disorders; Severity of Illness Index; Thiazoles; Treatment Outcome | 2000 |
Oral meloxicam is effective in acute sciatica: two randomised, double-blind trials versus placebo or diclofenac.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Diclofenac; Double-Blind Method; Female; Humans; Male; Meloxicam; Middle Aged; Sciatica; Thiazines; Thiazoles | 2001 |
Meloxicam in acute episodes of soft-tissue rheumatism of the shoulder.
Topics: Acute Disease; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cyclooxygenase Inhibitors; Double-Blind Method; Female; Humans; Male; Meloxicam; Middle Aged; Piroxicam; Shoulder Pain; Thiazines; Thiazoles | 2001 |
Comparison of vedaprofen and meloxicam in dogs with musculoskeletal pain and inflammation.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Dog Diseases; Dogs; Female; Inflammation; Male; Meloxicam; Musculoskeletal Diseases; Naphthalenes; Pain; Propionates; Thiazines; Thiazoles; Treatment Outcome | 2002 |
Efficacy assessment of meloxicam, a preferential cyclooxygenase-2 inhibitor, in acute coronary syndromes without ST-segment elevation: the Nonsteroidal Anti-Inflammatory Drugs in Unstable Angina Treatment-2 (NUT-2) pilot study.
Topics: Acute Disease; Adult; Aged; Angina, Unstable; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Coronary Disease; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Electrocardiography; Endpoint Determination; Female; Fibrinolytic Agents; Follow-Up Studies; Heparin; Humans; Isoenzymes; Male; Meloxicam; Membrane Proteins; Middle Aged; Pilot Projects; Prostaglandin-Endoperoxide Synthases; Syndrome; Thiazines; Thiazoles; Treatment Outcome | 2002 |
Pidotimod in the prophylaxis of recurrent acute tonsillitis in childhood.
Topics: Acute Disease; Adolescent; Child; Child, Preschool; Double-Blind Method; Female; Humans; Male; Pyrrolidonecarboxylic Acid; Recurrence; Thiazoles; Thiazolidines; Tonsillitis | 1992 |
Comparison of nizatidine and cimetidine as once-nightly treatment of acute duodenal ulcer. Nizatidine Multicenter Duodenal Ulcer Study Group.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Alcohol Drinking; Cimetidine; Creatinine; Double-Blind Method; Drug Administration Schedule; Duodenal Ulcer; Female; Histamine H2 Antagonists; Humans; Male; Middle Aged; Multicenter Studies as Topic; Nizatidine; Patient Compliance; Random Allocation; Smoking; Thiazoles | 1989 |
[Clinical evaluation of letosteine activity in the treatment of acute febrile bronchitis in children. Double-blind controlled study versus placebo].
Topics: Acute Disease; Bronchitis; Bronchospirometry; Child; Child, Preschool; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Expectorants; Female; Fever; Humans; Male; Thiazoles; Thiazolidines | 1989 |
Famotidine in the treatment of gastric and duodenal ulceration: overview of clinical experience.
Topics: Acute Disease; Chronic Disease; Cimetidine; Circadian Rhythm; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Duodenal Ulcer; Endoscopy; Famotidine; Gefarnate; Histamine H2 Antagonists; Humans; Ranitidine; Stomach Ulcer; Thiazoles; Time Factors | 1985 |
Review of an extensive worldwide study of a new H2-receptor antagonist, famotidine, as compared to ranitidine in the treatment of acute duodenal ulcer.
Topics: Acute Disease; Adult; Antacids; Duodenal Ulcer; Famotidine; Female; Histamine H2 Antagonists; Humans; Male; Middle Aged; Pain; Ranitidine; Thiazoles | 1987 |
Famotidine once-a-day in the therapy of acute, benign gastric ulcer: a worldwide experience.
Topics: Acute Disease; Adult; Antacids; Double-Blind Method; Drug Administration Schedule; Famotidine; Histamine H2 Antagonists; Humans; Stomach Ulcer; Thiazoles | 1987 |
Famotidine versus cimetidine in the treatment of acute duodenal ulcer. Double-blind, randomized clinical trial comparing nocturnal administration of 40 mg famotidine to 800 mg cimetidine.
Topics: Acute Disease; Adult; Aged; Anti-Ulcer Agents; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Famotidine; Female; Humans; Male; Middle Aged; Pain; Random Allocation; Thiazoles | 1988 |
[Acute therapy of duodenal ulcer. Comparison of famotidine and ranitidine in a single evening dose].
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Ulcer Agents; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Duodenal Ulcer; Famotidine; Female; Humans; Male; Middle Aged; Ranitidine; Thiazoles | 1987 |
[Clinical experiments with a new derivative of 6-aminopenicillanic acid: hetacillin potassium].
Topics: Acute Disease; Administration, Oral; Adult; Aged; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Child; Clinical Trials as Topic; Drug Combinations; Drug Synergism; Drug Tolerance; Evaluation Studies as Topic; Female; Humans; Imidazoles; Infant; Injections, Intramuscular; Lidocaine; Male; Meningitis; Middle Aged; Penicillins; Pyelonephritis; Thiazoles | 1972 |
85 other study(ies) available for thiazoles and Acute Disease
| Article | Year |
|---|---|
[Antithrombotic Treatment of Pulmonary Embolism].
Topics: Acute Disease; Dalteparin; Dose-Response Relationship, Drug; Drug Administration Schedule; Fibrinolytic Agents; Fondaparinux; Guideline Adherence; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Humans; Long-Term Care; Neoplasms; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Recurrence; Risk Assessment; Risk Factors; Rivaroxaban; Thiazoles | 2020 |
Effects of β3-adrenoceptor agonist on acute urinary retention in a rat model.
Topics: Acetanilides; Acute Disease; Adrenergic beta-3 Receptor Agonists; Animals; Disease Models, Animal; Rats; Rats, Sprague-Dawley; Thiazoles; Urinary Retention | 2021 |
RORγt inhibitor SR1001 alleviates acute pancreatitis by suppressing pancreatic IL-17-producing Th17 and γδ-T cells in mice with ceruletide-induced pancreatitis.
Topics: Acute Disease; Adult; Aged; Animals; Case-Control Studies; Ceruletide; Disease Models, Animal; Disease Progression; Female; Humans; Interleukin-17; Intraepithelial Lymphocytes; Leukocytes, Mononuclear; Male; Mice; Mice, Inbred C57BL; Middle Aged; Nuclear Receptor Subfamily 1, Group F, Member 3; Pancreatitis; Sulfonamides; Th17 Cells; Thiazoles | 2021 |
Edoxaban improves acute venous thromboembolism while preserving protein C and protein S levels.
Topics: Acute Disease; Aged; Anticoagulants; Antithrombin III; Female; Humans; Male; Middle Aged; Protein C; Protein S; Pulmonary Embolism; Pyridines; Thiazoles; Treatment Outcome; Venous Thromboembolism; Warfarin | 2018 |
Evaluation of nitazoxanide as a novel drug for the treatment of acute and chronic toxoplasmosis.
Topics: Acute Disease; Animals; Antiparasitic Agents; Chronic Disease; Disease Models, Animal; Mice; Nitro Compounds; Thiazoles; Toxoplasma; Toxoplasmosis | 2019 |
New oral anticoagulants for acute venous thromboembolism.
Topics: Acute Disease; Anticoagulants; Benzimidazoles; Dabigatran; Drug Approval; Humans; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thiophenes; Treatment Outcome; Venous Thromboembolism | 2014 |
Medical management of acute ocular hypertension in a western screech owl (Megascops kennicottii).
Topics: Acute Disease; Animals; Bird Diseases; Carbonic Anhydrase Inhibitors; Diclofenac; Mannitol; Meloxicam; Ocular Hypertension; Strigiformes; Sulfonamides; Thiazines; Thiazoles; Thiophenes | 2014 |
Prevalence, clinical presentation and treatment outcome of cryptosporidiosis in immunocompetent adult patients presenting with acute diarrhoea.
Topics: Acute Disease; Adult; Animals; Antiparasitic Agents; Cryptosporidiosis; Diarrhea; Female; Humans; Male; Middle Aged; Nitro Compounds; Pakistan; Prevalence; Prospective Studies; Thiazoles; Treatment Outcome | 2014 |
[Dasatinib is an efficient therapy for central nervous system Philadelphia chromosome-positive mixed phenotype acute leukemia].
Topics: Acute Disease; Central Nervous System; Dasatinib; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Phenotype; Pyrimidines; Thiazoles | 2014 |
Effective reversal of edoxaban-associated bleeding with four-factor prothrombin complex concentrate in a rabbit model of acute hemorrhage.
Topics: Acute Disease; Animals; Blood Coagulation Factors; Blood Coagulation Tests; Chinchilla; Endpoint Determination; Female; Hemorrhage; Hemorrhagic Disorders; Hemostatics; In Vitro Techniques; Pyridines; Rabbits; Thiazoles; Thrombin | 2015 |
How I treat mixed-phenotype acute leukemia.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Biomarkers, Tumor; Chromosome Aberrations; Combined Modality Therapy; Dasatinib; Flow Cytometry; Fusion Proteins, bcr-abl; Humans; Immunophenotyping; Leukemia; Middle Aged; Myeloid Cells; Pyrimidines; Stem Cell Transplantation; T-Lymphocytes; Thiazoles; Transplantation, Homologous | 2015 |
Acute colitis presenting with hematochezia in a patient with chronic myeloid leukemia during dasatinib therapy.
Topics: Acute Disease; Adolescent; Colitis; Dasatinib; Gastrointestinal Hemorrhage; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Protein Kinase Inhibitors; Pyrimidines; Thiazoles | 2014 |
Notch pathway plays a novel and critical role in regulating responses of T and antigen-presenting cells in aGVHD.
Topics: Acute Disease; Animals; Antigen-Presenting Cells; Bone Marrow Transplantation; Diamines; Disease Models, Animal; Graft vs Host Disease; Histocompatibility Antigens; Histocompatibility Testing; Mice, Inbred BALB C; Mice, Inbred C57BL; Phenotype; Receptors, Notch; Signal Transduction; T-Lymphocytes; Thiazoles | 2017 |
Dasatinib-induced acute hepatitis.
Topics: Acute Disease; Adult; Chemical and Drug Induced Liver Injury; Dasatinib; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Pyrimidines; Thiazoles | 2008 |
Extrapyramidal side effects: could you identify them in the emergency department?
Topics: Acute Disease; Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Dopamine Antagonists; Dyskinesia, Drug-Induced; Dystonia; Emergency Nursing; Emergency Treatment; Female; Humans; Infant; Male; Muscle Rigidity; Nursing Assessment; Parkinson Disease, Secondary; Piperazines; Risk Factors; Risperidone; Syndrome; Thiazoles | 2009 |
Kit inhibitor APcK110 induces apoptosis and inhibits proliferation of acute myeloid leukemia cells.
Topics: Acute Disease; Apoptosis; Benzamides; Caspases; Cell Growth Processes; Cell Survival; Dasatinib; Drug Screening Assays, Antitumor; Humans; Imatinib Mesylate; Leukemia, Myeloid; Mutation; Oncogene Protein v-akt; Phosphorylation; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyrazoles; Pyridines; Pyrimidines; STAT3 Transcription Factor; Stem Cell Factor; Thiazoles | 2009 |
Gout Study Group: update on hyperuricemia and gout.
Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Colchicine; Diet; Europe; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Life Style; Prednisone; Prevalence; Thiazoles; United States; Uric Acid | 2009 |
Efficacy of ziprasidone in dysphoric mania: pooled analysis of two double-blind studies.
Topics: Acute Disease; Adult; Affect; Aged; Bipolar Disorder; Depression; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Thiazoles | 2010 |
Acute generalized exanthematous pustulosis: an enigmatic drug-induced reaction.
Topics: Acute Disease; Aged; Dexamethasone; Diagnosis, Differential; Drug Eruptions; Exanthema; Humans; Male; Meloxicam; Skin Diseases, Vesiculobullous; Thalidomide; Thiazines; Thiazoles | 2009 |
Allogenic bone marrow transplantation with fludarabine/busulfan16 conditioning regimen and dasatinib maintenance therapy for elderly Philadelphia-positive acute/advanced leukemia patients.
Topics: Acute Disease; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Chemotherapy, Adjuvant; Dasatinib; Humans; Immunosuppressive Agents; Leukemia; Male; Philadelphia Chromosome; Pyrimidines; Thiazoles; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2010 |
A case of acute colitis with severe rectal bleeding in a patient with chronic myeloid leukemia after dasatinib use.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Colitis; Cytarabine; Dasatinib; Female; Gastrointestinal Hemorrhage; Humans; Idarubicin; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Piperazines; Pyrimidines; Rectal Diseases; Thiazoles | 2010 |
Acute pancreatitis attributed to dietary indiscretion in a female mixed breed canine.
Topics: Acute Disease; Animal Feed; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Cell Count; Dehydration; Dog Diseases; Dogs; Female; Medical History Taking; Meloxicam; Pancreatitis; Quinuclidines; Radiography; Tachycardia; Thiazines; Thiazoles; Treatment Outcome; Vomiting | 2010 |
The current state of care in gout: Addressing the need for better understanding of an ancient disease.
Topics: Acute Disease; Aged; Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Gouty; Arthritis, Rheumatoid; Chronic Disease; Colchicine; Comorbidity; Disease Progression; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Male; Middle Aged; Patient Education as Topic; Quality of Life; Risk Factors; Thiazoles; Uric Acid; Uricosuric Agents; Xanthine Oxidase | 2010 |
Modulation of BDNF expression by repeated treatment with the novel antipsychotic lurasidone under basal condition and in response to acute stress.
Topics: Acute Disease; Animals; Antipsychotic Agents; Brain-Derived Neurotrophic Factor; Gene Expression Regulation; Isoindoles; Lurasidone Hydrochloride; Male; Rats; Rats, Sprague-Dawley; Stress, Psychological; Thiazoles | 2012 |
Peroxisome proliferator-activated receptor β/δ agonist GW0742 ameliorates cerulein- and taurocholate-induced acute pancreatitis in mice.
Topics: Acute Disease; Amylases; Animals; Cell Adhesion Molecules; Cell Movement; Ceruletide; Disease Models, Animal; Dose-Response Relationship, Drug; Lipase; Male; Mice; Mice, Inbred Strains; Neutrophils; Pancreatitis; PPAR delta; PPAR-beta; Taurocholic Acid; Thiazoles; Time Factors | 2012 |
Preclinical activity of a novel CRM1 inhibitor in acute myeloid leukemia.
Topics: Acrylamides; Acrylates; Acute Disease; Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Drug Evaluation, Preclinical; Exportin 1 Protein; Female; fms-Like Tyrosine Kinase 3; Humans; Kaplan-Meier Estimate; Karyopherins; Leukemia, Myeloid; Mice; Mice, Inbred NOD; Mice, SCID; Middle Aged; Receptors, Cytoplasmic and Nuclear; Thiazoles; Triazoles; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays; Young Adult | 2012 |
[Current approaches to the treatment of patients with acute low back pain].
Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Humans; Low Back Pain; Meloxicam; Thiazines; Thiazoles | 2012 |
Nephrotic syndrome and acute tubular necrosis due to meloxicam use.
Topics: Acute Disease; Aged; Anti-Inflammatory Agents, Non-Steroidal; Female; Humans; Kidney Tubules; Meloxicam; Necrosis; Nephrotic Syndrome; Thiazines; Thiazoles | 2012 |
Cellular drug resistance in childhood acute myeloid leukemia is related to chromosomal abnormalities.
Topics: Acute Disease; Adolescent; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Chromosome Aberrations; Chromosome Inversion; Chromosomes, Human; Cladribine; Cytarabine; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Infant; Leukemia, Myeloid; Male; Neoplastic Stem Cells; Recurrence; Remission Induction; Tetrazolium Salts; Thiazoles; Translocation, Genetic; Trisomy | 2002 |
Antineoplastic effect of new boron compounds against leukemic cell lines and cells from leukemic patients.
Topics: Acute Disease; Antineoplastic Agents; Apoptosis; Boron Compounds; Cell Division; Guanidines; HL-60 Cells; Humans; Leukemia, Lymphoid; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Tetrazolium Salts; Thiazoles; Thymidine; U937 Cells | 2002 |
Two cases of acute polyarthritis secondary to intravesical BCG adjuvant therapy for superficial bladder cancer.
Topics: Acute Disease; Administration, Intravesical; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Arthritis, Infectious; BCG Vaccine; Humans; Indomethacin; Male; Meloxicam; Middle Aged; Thiazines; Thiazoles; Treatment Outcome; Urinary Bladder Neoplasms | 2002 |
Peroxisome proliferator-activated receptor gamma agonist ligands stimulate a Th2 cytokine response and prevent acute colitis.
Topics: Acute Disease; Animals; Antibody Formation; Antioxidants; Chromans; Colitis; Cytokines; Disease Models, Animal; Hypoglycemic Agents; Ligands; Mice; Mice, Inbred C57BL; Pioglitazone; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Th2 Cells; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone | 2002 |
[First i.m., now oral. COX-2 inhibitor in acute lumbago].
Topics: Acute Disease; Administration, Oral; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Humans; Injections, Intramuscular; Isoenzymes; Low Back Pain; Meloxicam; Membrane Proteins; Piroxicam; Prostaglandin-Endoperoxide Synthases; Randomized Controlled Trials as Topic; Thiazines; Thiazoles | 2002 |
A cohort study of the incidence of serious acute liver injury in diabetic patients treated with hypoglycemic agents.
Topics: Acute Disease; Adult; Aged; Chemical and Drug Induced Liver Injury; Chromans; Cohort Studies; Female; Humans; Hypoglycemic Agents; Incidence; Insulin; Liver; Liver Failure; Male; Metformin; Middle Aged; Proportional Hazards Models; Severity of Illness Index; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones; Troglitazone | 2003 |
Acute thrombocytopenic purpura due to meloxicam.
Topics: Acute Disease; Arthralgia; Cyclooxygenase Inhibitors; Female; Humans; Isoenzymes; Meloxicam; Middle Aged; Purpura, Thrombocytopenic; Thiazines; Thiazoles | 2003 |
Effect of carprofen, etodolac, meloxicam, or butorphanol in dogs with induced acute synovitis.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Butorphanol; Carbazoles; Dog Diseases; Dogs; Female; Male; Meloxicam; Narcotic Antagonists; Pain; Synovitis; Thiazines; Thiazoles | 2003 |
Introduction. Ziprasidone in schizophrenia: from acute treatment to long-term management.
Topics: Acute Disease; Antipsychotic Agents; Chronic Disease; Clinical Trials as Topic; Humans; Long-Term Care; Piperazines; Schizophrenia; Schizophrenic Psychology; Serotonin Antagonists; Thiazoles | 2003 |
Pifithrin-alpha protects against doxorubicin-induced apoptosis and acute cardiotoxicity in mice.
Topics: Acute Disease; Animals; Antibiotics, Antineoplastic; Apoptosis; Benzothiazoles; Cell Line, Tumor; Creatine Kinase; Doxorubicin; Gene Expression; Heart; Heart Diseases; Mice; Mice, Inbred ICR; Myocardium; Thiazoles; Toluene; Tumor Suppressor Protein p53 | 2004 |
Acute dystonic reaction with moderate-dose ziprasidone.
Topics: Acute Disease; Adult; Alcoholism; Antipsychotic Agents; Cocaine-Related Disorders; Dystonic Disorders; Female; Hallucinations; Humans; Piperazines; Risk Factors; Thiazoles; Tongue Diseases; Torticollis; Violence | 2004 |
[Application of meloxicam in scheme of prophylaxis of postoperative complications in patients with an acute ileus of tumoral etiology].
Topics: Acute Disease; Antineoplastic Agents; Colonic Neoplasms; Female; Humans; Ileus; Male; Meloxicam; Neoplasm Staging; Postoperative Complications; Thiazines; Thiazoles | 2004 |
[Risk of QTc prolongation due to combination of ziprasidone and quetiapine].
Topics: Acute Disease; Aged; Antipsychotic Agents; Dibenzothiazepines; Drug Interactions; Drug Therapy, Combination; Electrocardiography; Hallucinations; Humans; Long QT Syndrome; Male; Piperazines; Quetiapine Fumarate; Schizophrenia, Paranoid; Thiazoles | 2004 |
Intramuscular ziprasidone for acute agitation in adolescents.
Topics: Acute Disease; Adolescent; Aggression; Child; Humans; Injections, Intramuscular; Male; Piperazines; Psychomotor Agitation; Thiazoles | 2004 |
Ziprasidone-induced acute dystonia.
Topics: Acute Disease; Antipsychotic Agents; Basal Ganglia Diseases; Dose-Response Relationship, Drug; Drug Administration Schedule; Dystonia; Humans; Male; Middle Aged; Piperazines; Schizophrenia, Paranoid; Thiazoles | 2005 |
Ziprasidone pretreatment attenuates the lethal effects of cocaine in a mouse model.
Topics: Acute Disease; Animals; Antipsychotic Agents; Cocaine; Cocaine-Related Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Overdose; Injections, Intraperitoneal; Mice; Piperazines; Premedication; Random Allocation; Seizures; Single-Blind Method; Survival Analysis; Thiazoles; Treatment Outcome | 2005 |
Inducible cyclooxygenase released prostaglandin mediates immunosuppression in acute phase of experimental Trypanosoma cruzi infection.
Topics: Acute Disease; Animals; Cells, Cultured; Chagas Disease; Concanavalin A; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Cytokines; Dinoprostone; Immune Tolerance; Lymphocyte Activation; Male; Meloxicam; Mice; Mice, Inbred BALB C; Parasitemia; Prostaglandin-Endoperoxide Synthases; Sodium Salicylate; Spleen; T-Lymphocytes; Thiazines; Thiazoles | 2005 |
Cardiovascular events associated with long-term use of celecoxib, rofecoxib and meloxicam in Taiwan: an observational study.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Angina Pectoris; Cardiovascular Diseases; Celecoxib; Cyclooxygenase 2 Inhibitors; Databases, Factual; Female; Humans; Insurance, Pharmaceutical Services; Ischemic Attack, Transient; Lactones; Male; Meloxicam; Middle Aged; Myocardial Infarction; National Health Programs; Proportional Hazards Models; Pyrazoles; Risk Assessment; Stroke; Sulfonamides; Sulfones; Taiwan; Thiazines; Thiazoles; Time Factors | 2006 |
Ziprasidone-induced acute dystonic reactions in patients with bipolar disorder.
Topics: Acute Disease; Adult; Antipsychotic Agents; Bipolar Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Male; Piperazines; Thiazoles | 2006 |
Aromatic interactions with phenylalanine 691 and cysteine 828: a concept for FMS-like tyrosine kinase-3 inhibition. Application to the discovery of a new class of potential antileukemia agents.
Topics: Acute Disease; Adenosine Triphosphate; Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Cysteine; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid; Models, Molecular; Mutation; Phenylalanine; Protein Structure, Tertiary; Thiazoles | 2006 |
Current status of anti-diarrheal and anti-secretory drugs in the management of acute childhood diarrhea.
Topics: Acute Disease; Antidiarrheals; Antiparasitic Agents; Child; Child, Preschool; Cholera; Diarrhea; Disease Outbreaks; Dysentery, Bacillary; Female; Humans; Infant; Intestinal Diseases, Parasitic; Male; Nitro Compounds; Probiotics; Thiazoles; Thiorphan | 2006 |
A small-molecule c-Myc inhibitor, 10058-F4, induces cell-cycle arrest, apoptosis, and myeloid differentiation of human acute myeloid leukemia.
Topics: Acute Disease; Antineoplastic Agents; Apoptosis; Basic-Leucine Zipper Transcription Factors; Cell Cycle; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Dimerization; Down-Regulation; Drug Screening Assays, Antitumor; G1 Phase; HL-60 Cells; Humans; Leukemia, Myeloid; Myeloid Cells; Proto-Oncogene Proteins c-myc; Resting Phase, Cell Cycle; Structure-Activity Relationship; Thiazoles; U937 Cells; Up-Regulation | 2006 |
A naturalistic evaluation of intramuscular ziprasidone versus intramuscular olanzapine for the management of acute agitation and aggression in children and adolescents.
Topics: Acute Disease; Adolescent; Aggression; Antipsychotic Agents; Benzodiazepines; Child; Ethnicity; Female; Humans; Injections, Intramuscular; Inpatients; Male; Olanzapine; Piperazines; Psychomotor Agitation; Retrospective Studies; Sex Characteristics; Thiazoles; Treatment Outcome | 2006 |
Expression of multidrug resistance (MDR) proteins and in vitro drug resistance in acute leukemias.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Cell Survival; Child; Child, Preschool; Coloring Agents; Cytarabine; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Infant; Inhibitory Concentration 50; Leukemia; Leukemia, Myeloid; Male; Methylphenazonium Methosulfate; Middle Aged; Neoplasm Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Staining and Labeling; Tetrazolium Salts; Thiazoles; Treatment Outcome; Tumor Cells, Cultured | 2007 |
Atypical antipsychotic drug-induced acute laryngeal dystonia: 2 case reports.
Topics: Acute Disease; Adult; Antipsychotic Agents; Bipolar Disorder; Dystonia; Humans; Laryngeal Diseases; Male; Middle Aged; Piperazines; Thiazoles | 2007 |
Acute urinary retention associated with selective serotonin reuptake inhibitors and ziprasidone.
Topics: Acute Disease; Antipsychotic Agents; Depressive Disorder, Major; Drug Monitoring; Electroconvulsive Therapy; Humans; Male; Middle Aged; Piperazines; Receptors, Serotonin, 5-HT2; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Thiazoles; Urinary Catheterization; Urinary Retention | 2007 |
Effects of an ophthalmic formulation of meloxicam on COX-2 expression, PGE2 release, and cytokine expression in a model of acute ocular inflammation.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aqueous Humor; Cornea; Croton Oil; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cytokines; Dinoprostone; Disease Models, Animal; Down-Regulation; Drug Evaluation, Preclinical; Endophthalmitis; Male; Meloxicam; Ophthalmic Solutions; Rabbits; RNA, Messenger; Thiazines; Thiazoles | 2008 |
Ziprasidone for drug-induced psychotic symptoms in Parkinson's Disease.
Topics: Acute Disease; Antipsychotic Agents; Brief Psychiatric Rating Scale; Carbidopa; Drug Combinations; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Piperazines; Psychoses, Substance-Induced; Thiazoles | 2008 |
Parvovirus B19 acute infection and a reactivation of cytomegalovirus and herpesvirus 6 in a chronic myeloid leukemia patient during treatment with dasatinib (BMS-354825).
Topics: Acute Disease; Cytomegalovirus; Dasatinib; Female; Herpesvirus 6, Human; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Parvoviridae Infections; Parvovirus B19, Human; Protein Kinase Inhibitors; Pyrimidines; Thiazoles; Virus Activation | 2007 |
Trypanosoma cruzi: the role of PGE2 in immune response during the acute phase of experimental infection.
Topics: Acute Disease; Animals; Cells, Cultured; Chagas Disease; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprostone; Etoricoxib; Fibrosis; Male; Meloxicam; Mice; Mice, Inbred BALB C; Myocardium; Parasitemia; Prostaglandins; Pyridines; Spleen; Sulfones; Thiazines; Thiazoles; Trypanosoma cruzi | 2008 |
Platonin, a photosensitizing cyanine dye, suppresses acute inflammation.
Topics: Acute Disease; Animals; Cycloheximide; Dexamethasone; Inflammation; Male; Mice; Mice, Inbred ICR; Rats; Rats, Inbred Strains; Thiazoles | 1983 |
Preliminary observations on the effects of meloxicam in a new model for acute intra-articular inflammation in dogs.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Diatrizoate Meglumine; Disease Models, Animal; Dog Diseases; Dogs; Female; Leukocyte Count; Male; Meloxicam; Shoulder Joint; Synovial Fluid; Thiazines; Thiazoles | 1994 |
Thiol metabolism and acute pancreatitis: trying to make the pieces fit.
Topics: Acute Disease; Animals; Ceruletide; Cysteine; Glutathione; Pancreas; Pancreatitis; Pyrrolidonecarboxylic Acid; Sulfhydryl Compounds; Thiazoles; Thiazolidines | 1994 |
A tetrazolium-based colorimetric MTT assay to quantitate human monocyte mediated cytotoxicity against leukemic cells from cell lines and patients with acute myeloid leukemia.
Topics: Acute Disease; Colorimetry; Cytotoxicity, Immunologic; Humans; Immunity, Cellular; Immunologic Techniques; In Vitro Techniques; Leukemia, Myeloid; Monocytes; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1994 |
Effect of various antiplatelet agents on acute arterial thrombosis in the rat.
Topics: Acute Disease; Amino Acid Sequence; Animals; Aspirin; Carotid Artery Thrombosis; Clopidogrel; Electric Stimulation; Hirudin Therapy; Male; Molecular Sequence Data; Oligopeptides; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Thiazoles; Thrombolytic Therapy; Thromboxane-A Synthase; Ticlopidine | 1993 |
An in vitro study of blast cell metabolism in acute myeloid leukaemia using the MTT assay.
Topics: Acute Disease; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Division; Cell Size; Drug Resistance, Multiple; Drug Screening Assays, Antitumor; Humans; Individuality; Leukemia, Myeloid; Reproducibility of Results; Tetrazolium Salts; Thiazoles | 1996 |
Effect on cell kill of addition of multidrug resistance modifiers cyclosporin A and PSC 833 to cytotoxic agents in acute myeloid leukaemia.
Topics: Acute Disease; Adolescent; Adult; Aged; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cell Survival; Coloring Agents; Cyclosporine; Cyclosporins; Cytarabine; Daunorubicin; Drug Resistance, Neoplasm; Drug Synergism; Etoposide; Female; Humans; Idarubicin; Leukemia, Myeloid; Male; Middle Aged; Mitoxantrone; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1997 |
Lubeluzole treatment of acute ischemic stroke.
Topics: Acute Disease; Brain Ischemia; Cardiovascular Agents; Cerebrovascular Disorders; Humans; Piperidines; Thiazoles | 1998 |
Potential interaction of troglitazone and cyclosporine.
Topics: Acute Disease; Chromans; Cyclosporine; Drug Interactions; Female; Graft Rejection; Humans; Hypoglycemic Agents; Immunosuppressive Agents; Middle Aged; Osmolar Concentration; Thiazoles; Thiazolidinediones; Troglitazone | 1998 |
Modulation of resistance to ara-C by bryostatin in fresh blast cells from patients with AML.
Topics: Acute Disease; Antineoplastic Agents; Arabinofuranosylcytosine Triphosphate; Bryostatins; Cell Death; Cytarabine; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Lactones; Leukemia, Myeloid; Leukocytes, Mononuclear; Macrolides; Tetrazolium Salts; Thiazoles | 1998 |
Acute liver injury associated with the use of ebrotidine, a new H2-receptor antagonist.
Topics: Acute Disease; Adult; Aged; Alanine Transaminase; Aspartate Aminotransferases; Benzenesulfonates; Bilirubin; Chemical and Drug Induced Liver Injury; Female; Histamine H2 Antagonists; Humans; Liver; Liver Failure; Male; Middle Aged; Necrosis; Thiazoles | 1999 |
Lubeluzole. JK 8792, R 87926, Prosynap.
Topics: Acute Disease; Brain Ischemia; Drugs, Investigational; Humans; Neuroprotective Agents; Piperidines; Stroke; Thiazoles | 1999 |
Effect of ebrotidine on gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide.
Topics: Acute Disease; Animals; Anti-Ulcer Agents; Benzenesulfonates; Disease Models, Animal; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Lipopolysaccharides; Rats; Rats, Sprague-Dawley; Thiazoles | 1999 |
Acute orthostatic hypotension when starting dopamine agonists in Parkinson's disease.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Benzothiazoles; Dopamine Agonists; Drug Administration Schedule; Female; Humans; Hypotension, Orthostatic; Indoles; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Severity of Illness Index; Thiazoles | 2000 |
Sustaining short-term gains for future progress.
Topics: Acute Disease; Administration, Oral; Antipsychotic Agents; Humans; Injections, Intramuscular; Piperazines; Psychotic Disorders; Thiazoles | 2001 |
Distribution of coronary arterial flow in acute myocardial ischemia.
Topics: Acute Disease; Animals; Collateral Circulation; Coronary Circulation; Coronary Disease; Coronary Vessels; Dogs; Electrocardiography; Female; Fluorescent Dyes; Male; Methylene Blue; Myocardium; Papillary Muscles; Thiazoles | 1975 |
In vitro chemosensitivity of lymphoblasts at relapse in childhood leukemia using the MTT assay.
Topics: Acute Disease; Antineoplastic Agents; Child; Colorimetry; Drug Resistance; Drug Screening Assays, Antitumor; Humans; Leukemia; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1991 |
[Effects of etozoline in patients with acute cardiac failure].
Topics: Acute Disease; Aged; Antihypertensive Agents; Female; Heart Failure; Humans; Male; Middle Aged; Thiazoles | 1991 |
Comparative acute ototoxicity of loop diuretic compounds.
Topics: Acute Disease; Animals; Bumetanide; Chinchilla; Cochlea; Diuretics; Dose-Response Relationship, Drug; Ethacrynic Acid; Evoked Potentials, Auditory; Furosemide; Indans; Stereoisomerism; Sulfonamides; Thiazoles; Time Factors | 1991 |
Ventricular histamine concentrations and arrhythmias during acute myocardial ischaemia in rats.
Topics: Acute Disease; Animals; Arrhythmias, Cardiac; Blood Pressure; Coronary Disease; Guanidines; Heart Rate; Heart Ventricles; Histamine; Histamine Release; Male; Myocardium; Rats; Rats, Inbred Strains; Rhodanine; Thiazoles | 1987 |
Altered kinetics of etozolin and its active metabolite ozolinone in hepatitis and hepatic cirrhosis with ascites.
Topics: Acute Disease; Adult; Aged; Ascites; Ascitic Fluid; Diuretics; Half-Life; Hepatitis, Viral, Human; Humans; Liver Cirrhosis; Male; Middle Aged; Thiazoles | 1987 |
Evidence that platelet activating factor may mediate some acute inflammatory responses. Studies with the platelet-activating factor antagonist, CV3988.
Topics: Acute Disease; Animals; Blood Platelets; Capillary Permeability; Cell Movement; Inflammation; Leukocytes; Male; N-Formylmethionine Leucyl-Phenylalanine; Neutropenia; Phospholipid Ethers; Platelet Activating Factor; Rabbits; Regional Blood Flow; Serum Albumin; Skin; Thiazoles; Thrombocytopenia | 1986 |
Fentiazac in acute gouty arthritis.
Topics: Acetates; Acute Disease; Adult; Aged; Anti-Inflammatory Agents; Arthritis; Female; Gout; Humans; Male; Middle Aged; Thiazoles | 1985 |
Coronary venous perfusion of the ischemic myocardium during acute coronary artery occlusion in isolated rat hearts.
Topics: Acute Disease; Animals; Arterial Occlusive Diseases; Benzothiazoles; Coronary Disease; Coronary Vessels; Fluorescein; Fluoresceins; In Vitro Techniques; Male; Myocardium; NAD; Perfusion; Photography; Rats; Rats, Inbred Strains; Thiazoles | 1985 |
[Some peculiarities of the clinical aspects and therapy of acute pneumonia without leukocytosis].
Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; Blood Sedimentation; Cardiac Glycosides; Central Nervous System Stimulants; Eosinophils; Female; Humans; Leukocytosis; Lymphopenia; Male; Middle Aged; Monocytes; Nucleic Acids; Pneumonia; Respiratory Therapy; Sulfanilamides; Thiazoles; Uracil | 1974 |
Respiratory stimulants.
Topics: Acute Disease; Administration, Oral; Aminobutyrates; Benzamides; Carbon Dioxide; Carbonic Anhydrase Inhibitors; Chronic Disease; Dichlorphenamide; Doxapram; Humans; Infusions, Parenteral; Injections, Intramuscular; Injections, Intravenous; Nikethamide; Respiration; Respiratory Insufficiency; Stimulation, Chemical; Thiazoles | 1972 |
[Clinical data on treatment with 2-acetamido-4-(5-nitro-2-furyl)-thiazole in acute infectious enteritis in infants].
Topics: Acute Disease; Enteritis; Female; Humans; Infant; Male; Nitrofurans; Thiazoles | 1969 |